Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

46.77
BATS BZX Real-Time Price
As of 9:54am ET
 -1.38 / -2.88%
Today’s Change
37.73
Today|||52-Week Range
55.38
-2.41%
Year-to-Date

Today’s Trading

Previous close48.15
Today’s open48.00
Day’s range46.10 - 48.00
Volume150,372
Average volume (3 months)4,276,789
Market cap$23.9B
Dividend yield0.81%
Data as of 9:54am ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+0.82%
Earnings growth (next 5 years)+10.40%
Revenue growth (last year)-0.42%
P/E ratio69.1
Price/Sales5.05
Price/Book22.37

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-1.74-3.98%
VRTXVertex Pharmaceutica...-1.37-1.67%
ALXNAlexion Pharmaceutic...-2.07-1.43%
BMRNBiomarin Pharmaceuti...-2.38-2.80%
Data as of 10:54am ET, 05/04/2016

Financials

Last reporting dateMay 4, 2016
EPS forecast (this quarter)$0.40
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts

Partner Offers

Search for Jobs